Daniel Joseph Oconnell serves as Executive at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Joseph Oconnell has executed 17 insider transactions totaling $215.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved selling 2,689 shares valued at $5.1K.
Daniel Joseph Oconnell currently holds 881,275 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Joseph Oconnell has been a net seller of ABOS stock. They have purchased $0 and sold $215.9K worth of shares.
Daniel Joseph Oconnell's most recent insider trade was on Jan 22, 2026, when they sold 2,689 shares at $1.88 per share.
Get notified when new Form 4 filings are submitted
| $1.81 |
| Discretionary |
| Jan 20, 2026 | ABOS | $0 | Award | 450,000 | $N/A | Discretionary |
| Jan 20, 2026 | ABOS | $0 | Award | 299,800 | $N/A | Discretionary |
| Jan 12, 2026 | ABOS | $9.3K | Sale | 5,388 | $1.73 | Discretionary |
| Jan 9, 2026 | ABOS | $22.8K | Sale | 12,941 | $1.76 | Discretionary |
| Jan 8, 2026 | ABOS | $14.8K | Sale | 8,143 | $1.82 | Discretionary |
| Jan 7, 2026 | ABOS | $75.0K | Sale | 37,755 | $1.99 | Discretionary |
| Jan 6, 2026 | ABOS | $10.0K | Sale | 5,102 | $1.97 | Discretionary |
| Jan 5, 2026 | ABOS | $9.2K | Sale | 4,649 | $1.97 | Discretionary |
| Jan 19, 2024 | ABOS | $52.7K | Sale | 15,200 | $3.47 | Planned |
| Jan 2, 2024 | ABOS | $0 | Award | 401,000 | $N/A | Discretionary |
| Jan 17, 2023 | ABOS | $0 | Award | 114,000 | $N/A | Discretionary |
| Nov 30, 2021 | ABOS | $5.0K | Option Exercise | 1,118 | $4.47 | Discretionary |
| Jul 6, 2021 | ABOS | $160 | Payment | 10 | $16.00 | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 123 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $156 | Exercise | 35 | $4.47 | Discretionary |